Cuu Long Pharmaceutical JSC (HOSE:DCL)

Vietnam · Delayed Price · Currency is VND

44,400

+200 (0.45%)

At close: Nov 3, 2026

HOSE:DCL Financials Overview

Financials in millions VND. Fiscal year is January - December.

Millions VND. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,321,438	1,321,589	1,306,797	1,143,946	1,015,686	703,634
Revenue Growth	-9.45%	1.13%	14.24%	12.63%	44.35%	4.83%
Gross Profit	180,722	204,244	204,704	209,914	282,100	210,152
Operating Income	27,482	58,485	59,830	70,726	128,285	86,781
Net Income	-14,819	19,516	51,571	59,717	108,641	83,961
Earnings Per Share	-791.36	267.00	706.00	817.59	1548.00	1460.00
EPS Growth	-	-62.18%	-13.65%	-47.18%	6.03%	29.09%

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	728,777	126,364	156,292	118,570	161,647	558,148
Total Debt	959,672	778,435	754,843	630,730	513,592	500,297
Net Cash (Debt)	-230,895	-652,071	-598,551	-512,160	-351,945	57,851
Net Cash Growth	-	-	-	-	-	-66.40%
Net Cash Per Share	-12318.06	-8927.46	-8194.72	-7011.95	-5016.29	1006.12

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	69,944	47,791	69,813	22,530	-450,071	29,437
Capital Expenditures	-124,072	-88,040	-172,850	-222,874	-233,028	-152,612
Free Cash Flow	-54,129	-40,249	-103,037	-200,343	-683,099	-123,174
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	13.68%	15.45%	15.67%	18.35%	27.77%	29.87%
Operating Margin	2.08%	4.42%	4.58%	6.18%	12.63%	12.33%
Pretax Margin	0.03%	2.63%	5.26%	6.83%	13.94%	15.67%
Profit Margin	-1.12%	1.48%	3.95%	5.22%	10.70%	11.93%
FCF Margin	-4.10%	-3.05%	-7.89%	-17.51%	-67.25%	-17.51%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	160.93	37.89	30.58	16.47	27.89
PS Ratio	2.44	2.38	1.50	1.60	1.76	3.33